Bruker Current Deferred Revenue from 2010 to 2024
| BRKR Stock | USD 58.90 1.83 3.21% |
Current Deferred Revenue | First Reported 2001-12-31 | Previous Quarter 501.9 M | Current Value 466.7 M | Quarterly Volatility 114.3 M |
Check Bruker financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bruker's main balance sheet or income statement drivers, such as Interest Expense of 12.1 M, Total Revenue of 3.1 B or Gross Profit of 1.6 B, as well as many indicators such as Price To Sales Ratio of 5.18, Dividend Yield of 0.0026 or PTB Ratio of 14.38. Bruker financial statements analysis is a perfect complement when working with Bruker Valuation or Volatility modules.
Bruker | Current Deferred Revenue |
Latest Bruker's Current Deferred Revenue Growth Pattern
Below is the plot of the Current Deferred Revenue of Bruker over the last few years. It is revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends. Bruker's Current Deferred Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Bruker's overall financial position and show how it may be relating to other accounts over time.
| Current Deferred Revenue | 10 Years Trend |
|
Current Deferred Revenue |
| Timeline |
Bruker Current Deferred Revenue Regression Statistics
| Arithmetic Mean | 214,372,333 | |
| Geometric Mean | 176,309,586 | |
| Coefficient Of Variation | 51.68 | |
| Mean Deviation | 84,928,800 | |
| Median | 189,500,000 | |
| Standard Deviation | 110,792,307 | |
| Sample Variance | 12274.9T | |
| Range | 405.1M | |
| R-Value | 0.37 | |
| Mean Square Error | 11408.1T | |
| R-Squared | 0.14 | |
| Significance | 0.17 | |
| Slope | 9,169,661 | |
| Total Sum of Squares | 171849.1T |
Bruker Current Deferred Revenue History
About Bruker Financial Statements
Bruker shareholders use historical fundamental indicators, such as Current Deferred Revenue, to determine how well the company is positioned to perform in the future. Although Bruker investors may analyze each financial statement separately, they are all interrelated. The changes in Bruker's assets and liabilities, for example, are also reflected in the revenues and expenses on on Bruker's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 400 M | 420 M |
Pair Trading with Bruker
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bruker position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bruker will appreciate offsetting losses from the drop in the long position's value.Moving together with Bruker Stock
Moving against Bruker Stock
| 0.8 | EXEL | Exelixis | PairCorr |
| 0.75 | BMY | Bristol Myers Squibb Sell-off Trend | PairCorr |
| 0.56 | EWTX | Edgewise Therapeutics | PairCorr |
| 0.45 | KTTAW | Pasithea Therapeutics | PairCorr |
The ability to find closely correlated positions to Bruker could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bruker when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bruker - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bruker to buy it.
The correlation of Bruker is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bruker moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bruker moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Bruker can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Bruker Stock Analysis
When running Bruker's price analysis, check to measure Bruker's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bruker is operating at the current time. Most of Bruker's value examination focuses on studying past and present price action to predict the probability of Bruker's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bruker's price. Additionally, you may evaluate how the addition of Bruker to your portfolios can decrease your overall portfolio volatility.